Rapid risk assessment: Severe respiratory disease associated with a novel influenza A virus, A(H7N9) China
On 31 March 2013, the Chinese authorities announced the identification of a novel influenza A virus, A(H7N9), in three seriously ill people from two provinces presenting with respiratory infections. So far, no epidemiological link has been identified between those three patients. When testing for the influenza virus, the Chinese Center for Disease Control and Prevention identified genes from both A(H7N9) and A(H9N2) viruses, thus indicating a novel reassortant avian influenza A virus. In its initial assessment of the situation, the ECDC rapid risk assessment concludes that the risk of the spread of the virus in Europe can be considered low at this stage.
Human infection with a novel avian influenza virus, A(H7N9), China - 2nd update, 8 May 2013
This second update to ECDC's initial risk assessment concludes that the risk of the disease spreading to Europe via humans or through poultry is still low at this time.
Rapid risk assessment: Human infections with avian influenza A viruses, China
This Rapid Risk Assessment summarises the latest information about human infections with avian influenza A viruses in China.
Rapid risk assessment: human infection with avian influenza A(H5N1) virus, Egypt, 23 December 2014
According to a WHO update published on 4 December 2014, eight new human cases of influenza A(H5N1) have been reported in Egypt, with onset of disease in November 2014, bringing the total for 2014 to 12.
Rapid Risk Assessment: Human infection with influenza virus A(H7N9) virus - 4th update, 3 February 2015
This fourth update of the risk assessment on human infection with avian influenza A(H7N9) virus, summarises the epidemiological and virological information on the disease in China and Canada, and assesses the risk to public health in the EU/EEA and to EU/EEA citizens.
Situation overview: highly pathogenic avian influenza virus A of H5 type, 2 December 2015
This risk assessment looks at the risks of transmission in the EU/EEA and the options for response in connection with this localised outbreak.
Rapid risk assessment: Outbreaks of highly pathogenic avian influenza A(H5N8) in Europe, 18 November 2016
This Rapid Risk Assessment summarises the epidemiological, virological and environmental information relating to outbreaks of highly pathogenic avian influenza A virus subtype A(H5N8) in Europe up to 15 November 2016.
Rapid risk assessment: Potential resurgence of highly pathogenic H5N1 avian influenza
The increased reports of A(H5N1) outbreaks in poultry and wild bird populations, and the emergence of a further evolved lineage of the virus in poultry in some countries, do not change the current assessment of the risk to human health.
Rapid risk assessment: A(H5N1) Highly Pathogenic Avian Influenza in Egypt – Implications for human health in Europe
Highly pathogenic avian influenza A(H5N1) infections are continuing to occur in poultry and humans in Egypt. However there is no evidence of a significant change in the pattern of human illness and deaths related to A(H5N1) virus infections in the country. Certainly there are no epidemiological data or analyses consistent with adaptation of these viruses to humans.
Rapid risk assessment: Human fatality from highly pathogenic avian influenza A(H5N1) virus infection in Guangdong province, China
Following reports of a human fatality due to highly pathogenic avian influenza A(H5N1) virus infection in China’s Guangdong province, the European Commission requested an update to the assessment of risk of human-to-human transmission occurring. ECDC does not consider that there is any change to the previous assessments that the risk for EU/EEA countries is very low.